Your session is about to expire
← Back to Search
Cefiderocol for Pharmacokinetics
Study Summary
This trial is designed to assess how a new broad-spectrum antibiotic, Cefiderocol, is affected by continuous renal replacement therapies (CRRT), which are used to provide renal support for critically ill patients with acute kidney injury (AKI).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 3 trial • 300 Patients • NCT03032380Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant or breastfeeding.I do not have a condition that could lead to death within 48 hours.I am 18 years old or older.I am currently on continuous renal replacement therapy.
- Group 1: Cefiderocol
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current enrollment capacity for this clinical trial?
"Affirmative. According to clinicaltrials.gov, this scientific inquiry is currently on the search for volunteers as it was initially posted on July 25th 2022 and last modified August 1st 2022. 16 participants are needed from one location."
To what extent has Cefiderocol been found to be hazardous for individuals?
"Cefiderocol has limited clinical evidence supporting its efficacy and safety, so it garnered a score of 1."
Does this experiment allow for the participation of individuals aged 55 and over?
"This medical study outlines that the age range of participants is 18-120, with 3 separate studies for those younger and 29 trials specifically targeting older adults."
Which demographics meet the eligibility requirements for this clinical experiment?
"This medical investigation is recruiting up to 16 participants aged between 18 and 120 with pharmacokinetics. Additional criteria for these patients include being at least eighteen years old, as well receiving some form of continuous renal replacement therapy including CVVH, CVVHD, or CVVHDF support."
Is the recruitment process still open for this trial?
"That is correct. According to the clinicaltrials.gov website, this medical trial is actively seeking 16 participants from a single location and was initially posted on July 25th 2022 with its most recent update taking place August 1st of that same year."
Share this study with friends
Copy Link
Messenger